| 000 | 01230 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516070509.0 | ||
| 264 | 0 | _c20120531 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2011.38.4701 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPointreau, Yoann | |
| 245 | 0 | 0 |
_aFatal infusion reactions to cetuximab: role of immunoglobulin e-mediated anaphylaxis. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJan 2012 |
||
| 300 |
_a334; author reply 335 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aCommins, Scott P | |
| 700 | 1 | _aCalais, Gilles | |
| 700 | 1 | _aWatier, Hervé | |
| 700 | 1 | _aPlatts-Mills, Thomas A E | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 30 _gno. 3 _gp. 334; author reply 335 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2011.38.4701 _zAvailable from publisher's website |
| 999 |
_c21385087 _d21385087 |
||